anonymous
Guest
anonymous
Guest
I’m seeing reps announcing they’re joining Gilead oncology on LinkedIn. Fools
lotta blacks. Different world now.
I’m seeing reps announcing they’re joining Gilead oncology on LinkedIn. Fools
FoolTrov was entry to the market knowing it is a hard sell & likely will peak at 250mil but Mag was the drug that was going to be the blockbuster & brand for the Onc franchise then today it was delayed a year with organ failure.
Immunogenis sold Gilead cup fools gold.
I should never came over here from my prev company..... wonder if I can go back if they havent filled my pos?
Cadillac DeVille with 50 inch white walls jacked up with a 4 foot lift!!As long as they pay! What are the company car choices?
At least others have a curve & not dead in the water like Trovway safer than other oncology outfits where the flattening of the sales curve has occured.
Don’t even apply if you ain’t woke. And boosted. And black.
Kaboom!Our Oncology pipeline blew up yesterday.
What morons would rush hiring in 4wks and not wait for FDA decision---
Oh Joanna & Stu
Makes sense now of the poor judgements and leadership with timing.
2nd week on board and I am having 2nd regrets. Our ERD VP & Pres are clueless to what is needed to move a flatline drug that has developed a reputation by patients & now doctors as a dirty drug.
We need to scrap all this BS strategy & marketing stupid as Brand team developed & face head on these nasty side effect issues patients complain about. It will not get better & only worse as more more pts drop therapy so must address it and minimize.
I regret leaving my old co as Gilead Oncology leadership doesnt know what hell doing.
And the President is beyond clueless.... how did she get that high of a position?